Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Open-angle glaucoma often has no symptoms until vision loss begins, so regular screening is important. You can use eye drops ...

Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

Please provide your email address to receive an email when new articles are posted on . “Relaxation techniques have been reported to reduce IOP and improve neuroendocrine regulation of the ciliary ...

The cause of glaucoma is unknown, but it is accompanied by high eye pressure. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Glaucoma is a group ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

DelveInsight's“ Open-angle Glaucoma Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Open-angle Glaucoma pipeline landscape. It covers ...

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...